Open AccessRegione “Test”
Author(s) -
Roberto Gasparini,
Donatella Panatto,
Bruna Dirodi,
Rosa Prato,
Gianni Amunni,
Valter Turello,
Luigi Sudano,
Paolo Cristoforoni,
Sara Boccalini,
Paolo Bonanni
Publication year - 2012
Publication title -
farmeconomia/farmeconomia e percorsi terapeutici
Language(s) - English
Resource type - Journals
eISSN - 1721-6923
pISSN - 1721-6915
DOI - 10.7175/fe.v13i2s.471
Subject(s) - cohort , test (biology) , medicine , demography , meaning (existential) , vaccination , pediatrics , psychology , sociology , virology , paleontology , psychotherapist , biology
In “Test” region 75% of women (aged 24-64) are screened regularly, meaning every 3 years. A cost-effectiveness analysis shows that, considering regional tariffs, the multiple cohort (12-year-old + 25-year-old women) vaccination strategy with a 50% coverage, even if the coverage is much lower than 90%, could prevent 8 cases of cervicocarcinoma and 4 related deaths more than the vaccination of only 12-year-old girls, and thus proves to be cost-effective (8,721 €/QALY)